The prolyl cistrans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis

Oncogene

Volumn 28, Issue 44, 2009, Pages 3915-3925

  Baum, N ^a   Schiene Fischer, C ^b   Frost, M ^b   Schumann, M ^b   Sabapathy, K ^c   Ohlenschlager O ^a   Grosse, F ^a   Schlott, B ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b Max Planck Research Unit for Protein Folding   (Germany)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Apoptosis; Cell cycle; Cyclosporin; Genetic polymorphism; Peptidyl prolyl cis trans isomerization

Indexed keywords

CYCLOPHILIN; DNA; ISOMERASE; PROLINE; PROTEIN P53; TP53 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE REGULATION; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REPORTER GENE; AMINO ACID SUBSTITUTION; BINDING SITE; CELL DIVISION; GENETICS; METABOLISM; MISSENSE MUTATION; PHYSIOLOGY; PROTEIN BINDING; PROTEIN FOLDING; TUMOR CELL LINE;

AMINO ACID SUBSTITUTION; APOPTOSIS; BINDING SITES; CELL DIVISION; CELL LINE, TUMOR; CYCLOPHILINS; G2 PHASE; HUMANS; MUTATION, MISSENSE; PROTEIN BINDING; PROTEIN FOLDING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70449131375     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.248     Document Type: Article

References (52)

1. Akakura S, Yoshida M, Yoneda Y, Horinouchi S. (2001). A role for Hsc70 in regulating nucleocytoplasmic transport of a temperature-sensitive p53 (p53Val-135). J Biol Chem 276: 14649-14657.
2. Albrechtsen N, Dornreiter I, Grosse F, Kim E, Wiesmuller L, Deppert W. (1999). Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene 18: 7706-7717.
3. Arevalo-Rodriguez M, Cardenas ME, Wu X, Hanes SD, Heitman J. (2000). Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase. EMBO J 19: 3739-3749.
4. Bauerschmidt C, Pollok S, Kremmer E, Nasheuer HP, Grosse F. (2007). Interactions of human Cdc45 with the Mcm2-7 complex, the GINS complex, and DNA polymerases delta and epsilon during S phase. Genes Cells 12: 745-758.
5. Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A et al. (2006). iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38: 1133-1141.
6. Braaten D, Luban J. (2001). Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J 20: 1300-1309.
7. Choi KJ, Piao YJ, Lim MJ, Kim JH, Ha J, Choe W et al. (2007). Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia-and cisplatin-induced cell death. Cancer Res 67: 3654-3662.
8. Dumont P, Leu JI, Della Pietra ACr, George DL, Murphy M. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33: 357-365.
9. Fanghanel J. (2003). Enzymatic catalysis of the peptidyl-prolyl bond rotation: are transition state formation and enzyme dynamics directly linked? Angew Chem Int Ed Engl 42: 490-492.
10. Fischer G, Bang H, Mech C. (1984). Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides. Biomed Biochim Acta 43: 1101-1111.
11. Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX. (1989). Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337: 476-478.
12. Fujimori F, Takahashi K, Uchida C, Uchida T. (1999). Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem Biophys Res Comm 265: 658-663.
13. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI et al. (1996). Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87: 1285-1294. (Pubitemid 27010111)
14. Harding MW, Handschumacher RE, Speicher DW. (1986). Isolation and amino acid sequence of cyclophilin. J Biol Chem 261: 8547-8555.
15. Harrison RK, Stein RL. (1990). Mechanistic studies of peptidyl prolyl cis-trans isomerase: evidence for catalysis by distortion. Biochemistry 29: 1684-1689.
16. Herman M, Weinstein T, Korzets A, Chagnac A, Ori Y, Zevin D et al. (2001). Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med 137: 14-20.
17. Howard BA, Furumai R, Campa MJ, Rabbani ZN, Vujaskovic Z, Wang XF et al. (2005). Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo. Cancer Res 65: 8853-8860.
18. Howard BA, Zheng Z, Campa MJ, Wang MZ, Sharma A, Haura E et al. (2004). Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer. Lung Cancer 46: 313-323.
19. Hsu T, McRackan D, Vincent TS, Gert de Couet H. (2001). Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis. Nature Cell Biol 3: 538-543.
20. Jensen P, Hansen S, M0ller B, Leivestad T, Pfeffer P, Geiran O et al. (1999). Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40: 177-186.
21. Johnson MD, Kinoshita Y, Xiang H, Ghatan S, Morrison RS. (1999). Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation. J Neurosci 19: 2996-3006.
22. King FW, Wawrzynow A, Hohfeld J, Zylicz M. (2001). Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. EMBO J 20: 6297-6305.
23. Lamb P, Crawford L. (1986). Characterization of the human p53 gene. Mol Cell Biol 6: 1379-1385.
24. Laptenko O, Prives C. (2006). Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 13: 951-961.
25. Larsson R, Bergh J, Nygren P. (1991). Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin. Anticancer Res 11: 455-459.
26. Liou YC, Ryo A, Huang HK, Lu PJ, Bronson R, Fujimori F et al. (2002). Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci USA 99: 1335-1340.
27. Liu W, Youn HD, Zhou XZ, Lu KP, Liu JO. (2001). Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1. FEBS Lett 496: 105-108.
28. Ma L, Wagner J, Rice JJ, Hu W, Levine AJ, Stolovitzky GA. (2005). A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci USA 102: 14266-14271.
29. Marks WH, Harding MW, Handschumacher R, Marks C, Lorber MI. (1991). The immunochemical distribution of cyclophilin in normal mammalian tissues. Transplantation 52: 340-345.
30. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. (1987). Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7: 961-963.
31. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M et al. (2007). Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 315: 659-663.
32. Price ER, Jin M, Lim D, Pati S, Walsh CT, McKeon FD. (1994). Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A. Proc Natl Acad Sci USA 91: 3931-3935.
33. Pyrzynska B, Serrano M, Martinez AC, Kaminska B. (2002). Tumor suppressor p53 mediates apoptotic cell death triggered by cyclosporin A. J Biol Chem 277: 14102-14108.
34. Rey O, Baluda MA, Park NH. (1999). Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratino-cytes. Oncogene 18: 827-831.
35. Rippmann JF, Hobbie S, Daiber C, Guilliard B, Bauer M, Birk J et al. (2000). Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ 11: 409-416.
36. Ross HJ, Cho J, Osann K, Wong SF, Ramsinghani N, Williams J et al. (1997). Phase I/II trial of low dose cyclosporin A with EP for advanced non-small cell lung cancer. Lung Cancer 18: 189-198.
37. Scheibel T, Buchner J. (1998). The Hsp90 complex-a super-chaperone machine as a novel drug target. Biochem Pharmacol 56: 675-682.
38. Shevchenko A, Wilm M, Vorm O, Mann M. (1996). Mass spectro-metric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.
39. Siddique M, Sabapathy K. (2006). Trp53-dependent DNA-repair is affected by the codon 72 polymorphism. Oncogene 25: 3489-3500.
40. Soe K, Hartmann H, Schlott B, Stevnsner T, Grosse F. (2002). The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro. Oncogene 21: 6614-6623.
41. Taylor WR, DePrimo SE, Agarwal A, Agarwal ML, Schonthal AH, Katula KS et al. (1999). Mechanisms of G2 arrest in response to overexpression of p53. Mol Biol Cell 10: 3607-3622.
42. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19: 1092-1100.
43. Vogelstein B, Lane D, Levine AJ. (2000). Surfing the p53 network. Nature 408: 307-310.
44. Vousden KH, Lane DP. (2007). p53 in health and disease. Nat Rev Mol Cell Biol 8: 275-283.
45. Whitesell L, Sutphin PD, Pulcini EJ, Martinez JD, Cook PH. (1998). The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol 18: 1517-1524.
46. Wulf G, Ryo A, Liou YC, Lu KP. (2003). The prolyl isomerase Pin1 in breast development and cancer. Breast Cancer Res 5: 76-82.
47. Wulf GM, Liou YC, Ryo A, Lee SW, Lu KP. (2002). The prolyl isomerase Pin1 in breast development and cancer. J Biol Chem 277: 47976-47979.
48. Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld JU et al. (1997). Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278: 1957-1960.
49. Yang WM, Inouye CJ, Seto E. (1995). Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity. J Biol Chem 270: 15187-15193.
50. Zacchi P, Gostissa M, Uchida T, Salvagno C, Avolio F, Volinia S et al. (2002). The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419: 853-857.
51. Zheng H, You H, Zhou XZ, Murray SA, Uchida T, Wulf G et al. (2002). The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 419: 849-853.
52. Zylicz M, King FW, Wawrzynow A. (2001). Hsp70 interactions with the p53 tumour suppressor protein. EMBO J 20: 4634-4638.